Your weekly roundup of the latest news from Drug Topics®.
Recommendations from the unanimous vote must be adopted by the FDA and CDC.
There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.
Mallya can provide convenience for insulin pen users; however, it has yet to be released in the United States.
SPL026 with supportive therapy sees positive results in patients with major depressive disorder.
Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.
DSCSA: Keys to full compliance
May 12th 2024Ready or not, DSCSA goes into full effect in November 2024. Not everyone in the supply chain is ready for the new requirements, but advance planning can help you protect patients, inventories, and your business. It's also an opportunity for you to build a competitive edge!
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.